SARS-CoV-2 and Burkholderia cenocepacia infection in a patient with Cystic Fibrosis: an unfavourable conjunction?
Data so far collected by Cystic Fibrosis (CF) patient registries and Centers consortia suggest that in most patients with CF (pwCF) COVID-19 is less severe than initially predicted [1]. However, a subset of pwCF with well known negative CF prognostic factors, like diabetes and severely impaired lung function,have been shown to be prone to worse COVID-19 outcomes [2].
Source: Journal of Cystic Fibrosis - Category: Respiratory Medicine Authors: C. Olcese, R. Casciaro, D. Pirlo, C. Debbia, E. Castagnola, F. Cresta, C. Castellani Tags: Case Report Source Type: research
More News: Burkholderia | COVID-19 | Cystic Fibrosis | Diabetes | Endocrinology | Respiratory Medicine | SARS